Drug data last refreshed 23h ago · AI intelligence enriched 1mo ago
NITROGEN, NF is an inhaled gas therapeutic approved by the FDA in 2013 under an NDA for use via inhalation as a dosage form. The product is a non-pharmacologic gas modality supplied by Advanced Solutions Life Sciences. Specific indications and mechanism of action data are not available in current records.
Product is in peak lifecycle stage with moderate competitive pressure (30%), suggesting stable market position but limited expansion opportunities for commercial teams.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts
Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts
Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care
Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients
Worked on NITROGEN, NF at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Zero linked job postings indicate limited active hiring around this product, suggesting a small, established team managing a stable market position. Career growth opportunities are constrained unless significant clinical or commercial expansion occurs.